SCHEMBL856431

SCHEMBL856431

O=c1nc[nH]c2c1CC=C2

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8486639 0.73 GSK3A (0.36)
SCHEMBL14603648 0.73
SCHEMBL3670371 0.72 ALDH1A1 (0.32) ALDH1A1
SCHEMBL1421150 0.70
SCHEMBL15416606 0.69
SCHEMBL856432 0.68 ALDH1A1 (0.39) ALDH1A1
SCHEMBL3542407 0.61 NPSR1 (0.41) ALDH1A1
SCHEMBL3672630 0.60 ALDH1A1 (0.32) ALDH1A1
SCHEMBL2321239 0.57 IDO1 (0.39)
SCHEMBL9851253 0.57 GSK3A (0.40) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3356345-A1 HETEROARYL DERIVATIVES AS SEPIAPTERIN REDUCTASE INHIBITORS Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2018-08-08 EP disclosed
EP-2432779-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES Exelixis, Inc. (US) 2012-03-28 EP disclosed
WO-2010135524-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES EXELIXIS, INC. (US) 2010-11-25 WO disclosed